OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation
Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Ali Sam Arian, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-18
Closed Access | Times Cited: 12
Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Ali Sam Arian, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-18
Closed Access | Times Cited: 12
Showing 12 citing articles:
Exploring the anti-amyloid potential of salvianolic acid A against the ALS-associated mutant SOD1: insights from molecular docking and molecular dynamic simulations
Zainab Abdullah Waheed, Bagher Seyedalipour, Abasalt Hosseinzadeh Colagar, et al.
Molecular Simulation (2024) Vol. 50, Iss. 13, pp. 899-917
Closed Access | Times Cited: 7
Zainab Abdullah Waheed, Bagher Seyedalipour, Abasalt Hosseinzadeh Colagar, et al.
Molecular Simulation (2024) Vol. 50, Iss. 13, pp. 899-917
Closed Access | Times Cited: 7
Discovering the therapeutic potential of Naringenin in diabetes related to GLUT4 and its regulatory factors: a computational approach
Ali Khakpour, Shamim Ghiabi, Ali Kazemi Babaheydari, et al.
Chemical Physics Impact (2024), pp. 100784-100784
Open Access | Times Cited: 5
Ali Khakpour, Shamim Ghiabi, Ali Kazemi Babaheydari, et al.
Chemical Physics Impact (2024), pp. 100784-100784
Open Access | Times Cited: 5
Discovery of effective GSK-3β inhibitors as therapeutic potential against Alzheimer's disease: A computational drug design insight
Fatemeh Sadat Seyedi Asl, Nasrin Malverdi, Fatemeh Mojahedian, et al.
International Journal of Biological Macromolecules (2025), pp. 141273-141273
Closed Access
Fatemeh Sadat Seyedi Asl, Nasrin Malverdi, Fatemeh Mojahedian, et al.
International Journal of Biological Macromolecules (2025), pp. 141273-141273
Closed Access
Structural insights into SOD1: from in silico and molecular dynamics to experimental analyses of ALS-associated E49K and R115G mutants
Seyed Mahdi Hosseini Faradonbeh, Bagher Seyedalipour, Nasrin Keivan Behjou, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Seyed Mahdi Hosseini Faradonbeh, Bagher Seyedalipour, Nasrin Keivan Behjou, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Identification of Novel Functional Single Nucleotide Polymorphisms in the BRCA1 Gene of Breast Cancer Patients
Mohsen Miresmaeili, Mohsen Nabi‐Afjadi, Ahmadreza Lagzian, et al.
Deleted Journal (2024)
Closed Access | Times Cited: 3
Mohsen Miresmaeili, Mohsen Nabi‐Afjadi, Ahmadreza Lagzian, et al.
Deleted Journal (2024)
Closed Access | Times Cited: 3
Mutation/metal deficiency in the "electrostatic loop" enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases
Faezeh Ashkaran, Bagher Seyedalipour, Payam Baziyar, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Faezeh Ashkaran, Bagher Seyedalipour, Payam Baziyar, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Therapeutic applications of melatonin in disorders related to the gastrointestinal tract and control of appetite
Atousa Moghadam Fard, Pardis Goodarzi, Mehran Mottahedi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5335-5362
Closed Access | Times Cited: 2
Atousa Moghadam Fard, Pardis Goodarzi, Mehran Mottahedi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5335-5362
Closed Access | Times Cited: 2
Therapeutic approaches in proteinopathies
Mohsen Nabi‐Afjadi, Bahareh Dabirmanesh, Vladimir N. Uversky
Progress in molecular biology and translational science (2024), pp. 341-388
Closed Access | Times Cited: 1
Mohsen Nabi‐Afjadi, Bahareh Dabirmanesh, Vladimir N. Uversky
Progress in molecular biology and translational science (2024), pp. 341-388
Closed Access | Times Cited: 1
Insight Into Factors Influencing the Aggregation Process in Wild‐Type and P66R Mutant SOD1 : Computational and Spectroscopic Approaches
Roghayeh Farrokhzad, Bagher Seyedalipour, Payam Baziyar, et al.
Proteins Structure Function and Bioinformatics (2024)
Closed Access | Times Cited: 1
Roghayeh Farrokhzad, Bagher Seyedalipour, Payam Baziyar, et al.
Proteins Structure Function and Bioinformatics (2024)
Closed Access | Times Cited: 1
Bisdemethoxycurcumin, a novel potent polyphenolic compound, effectively inhibits the formation of amyloid aggregates in ALS-associated hSOD1 mutant (L38R)
Zeinab Haghgoo Kouhi, Bagher Seyedalipour, Saman Hosseinkhani, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136701-136701
Closed Access
Zeinab Haghgoo Kouhi, Bagher Seyedalipour, Saman Hosseinkhani, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136701-136701
Closed Access
Neurodegenerative Marine Algae Bioactive Compounds: A Viable Cure to Treat Amyotrophic Lateral Sclerosis (ALS): A Review
Ali R. Mani, Mathiyazhagan Narayanan, V. Rajinikanth
Dubai Medical Journal (2024)
Open Access
Ali R. Mani, Mathiyazhagan Narayanan, V. Rajinikanth
Dubai Medical Journal (2024)
Open Access
Naringenin as a potent anti-amyloidogenic polyphenol against a-synuclein aggregation: a computational approach
Mohamed J. Saadh, Zahraa Sabah Ghnim, Morug Salih Mahdi, et al.
The European Physical Journal Plus (2024) Vol. 139, Iss. 12
Closed Access
Mohamed J. Saadh, Zahraa Sabah Ghnim, Morug Salih Mahdi, et al.
The European Physical Journal Plus (2024) Vol. 139, Iss. 12
Closed Access
